Palisade Bio, Inc.
PALI
$0.7556
-$0.0207-2.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -10.85% | -8.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.87% | -14.68% | |||
| Operating Income | 5.87% | 14.68% | |||
| Income Before Tax | 4.10% | 14.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.10% | 14.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.10% | 14.53% | |||
| EBIT | 5.87% | 14.68% | |||
| EBITDA | 5.85% | 14.68% | |||
| EPS Basic | 33.42% | 30.03% | |||
| Normalized Basic EPS | 33.42% | 30.03% | |||
| EPS Diluted | 33.42% | 30.03% | |||
| Normalized Diluted EPS | 33.42% | 30.03% | |||
| Average Basic Shares Outstanding | 44.03% | 22.13% | |||
| Average Diluted Shares Outstanding | 44.03% | 22.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||